Funder: Patient-Centered Outcomes Research Institute

Due Dates (Anticipated): May 2026 (Letter of Intent) | September 2026 (Full Application)

Funding Amounts: Up to $12 million direct costs per award (max 5 years); total funds available up to $60 million.

Summary: Supports patient-centered comparative effectiveness research addressing intentional trauma, unintentional trauma, and substance use/trauma, with emphasis on real-world impact and stakeholder engagement.

Key Information: This is a forecasted opportunity; all dates are projected and subject to change.